ALXN
Lazard Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-21,267
| Closed | -$3.91M | – | 2358 |
|
|
2021
Q2 | $3.91M | Buy |
21,267
+594
| +3% | +$109K | ﹤0.01% | 755 |
|
|
2021
Q1 | $3.16M | Buy |
20,673
+7,312
| +55% | +$1.12M | ﹤0.01% | 727 |
|
|
2020
Q4 | $2.09M | Sell |
13,361
-184
| -1% | -$28.7K | ﹤0.01% | 790 |
|
|
2020
Q3 | $1.55M | Sell |
13,545
-207
| -2% | -$23.7K | ﹤0.01% | 759 |
|
|
2020
Q2 | $1.54M | Sell |
13,752
-16,066
| -54% | -$1.8M | ﹤0.01% | 713 |
|
|
2020
Q1 | $2.68M | Buy |
29,818
+10,899
| +58% | +$978K | ﹤0.01% | 623 |
|
|
2019
Q4 | $2.05M | Buy |
18,919
+17,643
| +1,383% | +$1.91M | ﹤0.01% | 670 |
|
|
2019
Q3 | $124K | Sell |
1,276
-12
| -0.9% | -$1.17K | ﹤0.01% | 968 |
|
|
2019
Q2 | $168K | Buy |
1,288
+1,276
| +10,633% | +$166K | ﹤0.01% | 1050 |
|
|
2019
Q1 | $1K | Hold |
12
| – | – | ﹤0.01% | 1137 |
|
|
2018
Q4 | $1K | Hold |
12
| – | – | ﹤0.01% | 1016 |
|
|
2018
Q3 | $1K | Hold |
12
| – | – | ﹤0.01% | 1043 |
|
|
2018
Q2 | $1K | Hold |
12
| – | – | ﹤0.01% | 1022 |
|
|
2018
Q1 | $1K | Sell |
12
-44
| -79% | -$3.67K | ﹤0.01% | 1031 |
|
|
2017
Q4 | $6K | Buy |
56
+33
| +143% | +$3.54K | ﹤0.01% | 1005 |
|
|
2017
Q3 | $3K | Buy |
23
+11
| +92% | +$1.44K | ﹤0.01% | 955 |
|
|
2017
Q2 | $1K | Hold |
12
| – | – | ﹤0.01% | 1003 |
|
|
2017
Q1 | $1K | Hold |
12
| – | – | ﹤0.01% | 1007 |
|
|
2016
Q4 | $1K | Hold |
12
| – | – | ﹤0.01% | 986 |
|
|
2016
Q3 | $1K | Hold |
12
| – | – | ﹤0.01% | 982 |
|
|
2016
Q2 | $1K | Buy |
12
+6
| +100% | +$500 | ﹤0.01% | 1030 |
|
|
2016
Q1 | $0 | Hold |
6
| – | – | ﹤0.01% | 1135 |
|
|
2015
Q4 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 1093 |
|
|
2014
Q2 | – | Sell |
-1,200
| Closed | -$182K | – | 1082 |
|
|
2014
Q1 | $182K | Buy |
+1,200
| New | +$182K | ﹤0.01% | 832 |
|